Serum alanine aminotransferase levels and the detection of hepatitis C virus (HCV) in chronic HCV infections

Heath A Kelly, William J Maskill, William Sievert and D Scott Bowden
Med J Aust 2002; 176 (3): . || doi: 10.5694/j.1326-5377.2002.tb04333.x
Published online: 4 February 2002

To the Editor: Chronic hepatitis C virus (HCV) infection affects almost 200 000 Australians.1 It is monitored clinically by serial liver function tests (LFTs) and HCV RNA detection by polymerase chain reaction (PCR). HCV RNA is a marker of chronic infection and levels reflect response to antiviral therapy. However, testing for the presence of HCV RNA is expensive and, under the current Medicare Benefits Schedule, is not available to people with HCV antibodies and abnormal LFTs unless they are undergoing antiviral therapy.

  • Heath A Kelly
  • William J Maskill
  • William Sievert
  • D Scott Bowden



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.